There are currently 61 active clinical trials seeking participants for COVID19 research studies. The states with the highest number of trials for Autism participants are Florida, Texas, California and New York.
REsearching Covid-19 Outcomes in Diabetes (RECODE)
NCT04805970
Recruiting
The purpose of this study is to observe any changes that may occur to certain organs following a confirmed diagnosis of COVID-19 in people with and without diabetes.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/21/2023
Locations: AdventHealth Translational Research Institute, Orlando, Florida
Conditions: Covid19, Diabetes
Register for Updates
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays
NCT04562285
Recruiting
The primary objective is to assess the ability of COVID-19 IgG and IgM assays to detect an immune response in COVID-19 patients in the Henry Ford Health System (HFHS), both during hospitalization and over the following 12 months.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/18/2023
Locations: Henry Ford Health System, Detroit, Michigan
Conditions: Covid19
Register for Updates
Conversations You Want About Corona Virus Disease (COVID-19)
NCT05191420
Recruiting
Web-enabled virtual topical guide: develop virtual conversations for each concern and intensity level
Gender:
All
Ages:
18 years and above
Trial Updated:
06/27/2023
Locations: Wake Forest Health Sciences, Winston-Salem, North Carolina
Conditions: Covid19
Register for Updates
Evaluation of Aerosol in a Dental Clinic
NCT04659928
Recruiting
The purpose of this study is to evaluate the effectiveness of external evacuation units and mouth rinses during aerosol generating procedures in a dental clinic and to determine the risk level to the dental practitioners during aerosol generating procedures.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/02/2023
Locations: The University of Texas Health Science Center at Houston, Houston, Texas
Conditions: Covid19
Register for Updates
Study of Descartes-30 in Acute Respiratory Distress Syndrome
NCT04524962
Recruiting
Emergency study to test the safety of Descartes-30 cells in patients with moderate-to-severe acute respiratory distress syndrome (ARDS) AND COVID-19
Gender:
All
Ages:
18 years and above
Trial Updated:
02/06/2023
Locations: University of Iowa Hospitals and Clinics, Iowa City, Iowa +1 locations
Conditions: Acute Respiratory Distress Syndrome, Covid19
Register for Updates
Nebulised Heparin in Patients With Severe COVID-19
NCT04545541
Recruiting
The Can nebulised HepArin Reduce morTality and time to Extubation in Patients with COVID-19 Requiring mechanical ventilation Meta-Trial (CHARTER-MT) is a prospective collaborative individual patient data analysis of randomised controlled trials and early phase studies. Individual studies are being conducted in multiple countries, including Australia, Ireland, the USA, and the UK. Mechanically ventilated patients with confirmed or strongly suspected SARS-CoV-2 infection, hypoxaemia and an acute... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/31/2023
Locations: Frederick Health Hospital, Frederick, Maryland
Conditions: Covid19, Respiratory Failure
Register for Updates
Defibrotide for the Treatment of Severe COVID-19
NCT04652115
Recruiting
The goal of this study is to evaluate the safety and feasibility of defibrotide in COVID-19 pneumonia.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
01/03/2023
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Covid19
Register for Updates
Post Acute Sequelae of COVID-19
NCT04964115
Recruiting
COVID-19, a novel coronavirus, has caused widespread mortality and morbidity since it emerged in 2019. There is ongoing research and growing literature describing severe acute respiratory syndrome (SARS-COV-2). There is a growing population of individuals who have recovered from acute SARS-COV-2 infection. The long-term effects of COVID-19 are unknown. There are growing reports of sequelae after acute SARS-CoV-2 not limited to fatigue, dyspnea, reactive airway disease, organizing pneumonia, pulm... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/17/2022
Locations: Vanderbilt_University MC, Nashville, Tennessee
Conditions: Covid19, Sars-CoV-2 Infection, Dyspnea Caused by 2019-nCoV, COVID-19 Acute Respiratory Distress Syndrome, Pulmonary Fibrosis
Register for Updates
Relative Bioavailability, Safety, and Tolerability of Single-dose Sotrovimab Injection in Adults (COSMIC)
NCT05280717
Recruiting
This clinical pharmacology study will evaluate the relative bioavailability, safety, and tolerability of two different concentrations of sotrovimab injections administered at different injection sites in male or female healthy participants aged 18 to 65 years. The study will be conducted in three parts (Part A, an optional Part B and Part C).
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
11/02/2022
Locations: Investigative Site, Riverside, California +9 locations
Conditions: Covid19
Register for Updates
Cardiovascular, Pulmonary, and Integrative Functional Phenotypes in COVID-19 Survivors - Effect of Fenofibrate
NCT05080192
Recruiting
The International multicenter FEnofibRate as a Metabolic INtervention for COVID-19 (FERMIN) trial is being executed. The trial is testing a short intervention (10 days of fenofibrate therapy) on 30-day outcomes in COVID-19. The overarching goal of this sub-study is to explore the impact of fenofibrate on key longer term phenotypes of vascular, cardiac and pulmonary health, integrated cardiopulmonary function, persistent/chronic symptoms and quality of life.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/18/2022
Locations: University of Pennsylvania, Philadelphia, Pennsylvania
Conditions: Covid19
Register for Updates
COVID-19 Project ECHO in Nursing Homes
NCT04499391
Recruiting
Nursing homes are ground zero for the COVID-19 pandemic. Nursing homes are ill-equipped for the pandemic; though facilities are required to have infection control staff, only 3% have taken a basic infection control course. Significant research has focused on infection control in the acute care setting. However, little is known about the implementation of practices and effective interventions in long-term care facilities.The investigators propose an intervention utilizing Project ECHO, an evidenc... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/20/2022
Locations: Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania
Conditions: Covid19
Register for Updates
Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
NCT05046561
Recruiting
Protocol STRI12 - Study to Reinforce Immunity (STRI) - A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID-19 (the Study)
Gender:
All
Ages:
18 years and above
Trial Updated:
09/08/2022
Locations: Luna Research, Coral Gables, Florida +12 locations
Conditions: Covid19
Register for Updates